Unknown

Dataset Information

0

Current usage of stereotactic body radiotherapy for oligometastatic prostate cancer in Korea: patterns of care survey (KROG 19-08).


ABSTRACT:

Background

Growing evidence suggests that metastasis-directed therapy and/or prostate-directed therapy may benefit patients with oligometastatic prostate cancer (OMPC). Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastases in various cancers. The purpose of this study was to investigate the current patterns of curative-intent SBRT for OMPC in Korea.

Methods

A 20-item questionnaire was sent to 326 radiation oncologists in 93 institutions in Korea. Only 1 physician per institution was required to complete the survey. Subsequently, the second survey consisting of 3 clinical scenarios was sent to 64 physicians with clinical experience in SBRT: case 1, cT4N0M1 (direct invasion to two pelvic bones); case 2, cT2N0M1 (three bone metastases); and case 3, solitary spine metastasis after radical prostatectomy.

Results

Seventy-six physicians from 93 institutions (82%) answered the first survey. The multidisciplinary team approach was practiced in 16 institutions (21%). Most physicians (75%) agreed on the definition of oligometastases as limited lesions and/or organs ≤5: 25% agreed with low-volume disease according to CHAARTED trial. During the last year, 49 physicians (64%) treated OMPC patients with curative intent. Sixty four physicians (84%) had a clinical experience with SBRT: 48 (75%) stated that both dose and fraction number should be considered when defining SBRT, whereas others (25%) stated that only fraction size should be considered. Fifty-five faculties (86%) answered the second survey. Physicians agreed with oligometastases in 89% for case 1, in 80% for case 2, and in 100% for case 3. The rate of SBRT application was the highest in case 3 (70%).

Conclusions

There was diversity in the patterns of SBRT for OMPC in Korea. Additional prospective studies are necessary to strengthen evidence regarding role of SBRT in OMPC.

SUBMITTER: Bae SH 

PROVIDER: S-EPMC8422114 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Current usage of stereotactic body radiotherapy for oligometastatic prostate cancer in Korea: patterns of care survey (KROG 19-08).

Bae Sun Hyun SH   Jang Won Il WI   Kang Hyun-Cheol HC   Kim Young Il YI   Kim Yong Ho YH   Kim Woo Chul WC   Lee Hee Kwan HK   Kim Jin Ho JH  

Annals of translational medicine 20210801 16


<h4>Background</h4>Growing evidence suggests that metastasis-directed therapy and/or prostate-directed therapy may benefit patients with oligometastatic prostate cancer (OMPC). Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastases in various cancers. The purpose of this study was to investigate the current patterns of curative-intent SBRT for OMPC in Korea.<h4>Methods</h4>A 20-item questionnaire was sent to 326 radiation oncologists in 93 institutions in Korea. Only  ...[more]

Similar Datasets

| S-EPMC4066290 | biostudies-literature
| S-EPMC6868044 | biostudies-literature
| S-EPMC9735640 | biostudies-literature
| S-EPMC7716008 | biostudies-literature
| S-EPMC7577453 | biostudies-literature
| S-EPMC7278320 | biostudies-literature
| S-EPMC6885020 | biostudies-literature
| S-EPMC6863405 | biostudies-literature
| S-EPMC6069023 | biostudies-literature